Clin2
NCT06753890Possibly a fitNot yet recruiting

Changkang Granules for Diarrhea-Predominant IBS

Diarrhea-predominant Irritable Boewl Syndrome

Part of Digestive system clinical trials.

This trial tests if Changkang Granules can reduce abdominal pain and diarrhea in people with irritable bowel syndrome (IBS) where the main symptom is loose stools. It is specifically for those whose condition fits a pattern in traditional Chinese medicine called 'Liver qi affecting the Spleen.'

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
520 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with IBS with diarrhea (based on the Rome IV criteria).
  • You have had abdominal pain averaging at least a 3 on a 0-10 scale each week, and at least 2 days per week with very loose or watery stools (type 6 or 7 on the Bristol Stool Chart) during the run-in period.
  • You have had a colonoscopy within the last year that shows no serious issues, or only minor findings like small polyps (≤5mm and no more than 3) that your doctor says are okay.
  • You do not have major depression or anxiety (scores on standard questionnaires must be below certain cutoffs), and you have not taken certain medications for IBS, pain, or mental health in the last 4 weeks.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07610434Not yet recruiting· Phase 3
Traditional Chinese Medicine for Diarrhea-Dominant IBS

This trial tests whether Changji'an Capsules, a traditional Chinese medicine, can reduce symptoms of IBS with diarrhea (abdominal pain, bloating, and loose stools). The trial is for people aged 18–65 who have been diagnosed with this condition and may not have responded well to other treatments.

Beijing, Dongcheng District
NCT07061184Not yet recruiting· Phase 4
Testing Fengliao Changweikang for IBS with diarrhea

This trial is testing a Chinese herbal formula called Fengliao Changweikang for people with diarrhea-predominant irritable bowel syndrome (IBS-D). It uses an N-of-1 design, meaning each person serves as their own control to see if the treatment works for them.

Beijing, Beijing Municipality
NCT07721012Not yet recruiting· Phase 2
Huanghou Zhixie Diwan for IBS with Diarrhea

This trial tests a traditional Chinese medicine pill for people with irritable bowel syndrome where diarrhea is the main symptom. It's for those who have at least moderate abdominal pain and frequent loose stools, and meet specific traditional Chinese medicine criteria.

Beijing
NCT06737666Recruiting· Phase 1
Tong-Xie-Yao-Fang for Diarrhea-Predominant IBS

This trial tests an herbal formula called Tong-Xie-Yao-Fang for people with diarrhea-predominant irritable bowel syndrome (IBS-D). It aims to see if the treatment helps symptoms and how it works. Healthy volunteers are also needed for comparison.

Beijing, Beijing Municipality
NCT07715760Not yet recruiting
Hewei Anchang formula for overlapping stomach and bowel symptoms

This trial tests a traditional Chinese medicine formula (Hewei Anchang) for people who have both functional dyspepsia (upset stomach without clear cause) and diarrhea-predominant irritable bowel syndrome. It aims to see if the formula improves overlapping symptoms and how it works.

Beijing, Beijing Municipality
NCT07688161Not yet recruiting· Phase 3
Herbal granules for diarrhea-predominant IBS (cold-dampness type)

This study tests whether a traditional Chinese herbal formula called Jingfang Granules can ease diarrhea and belly pain in people with irritable bowel syndrome (IBS-D). It is for those whose IBS symptoms fit a specific pattern in Chinese medicine (cold-dampness).

Nanjing, Jiangsu

Hear when a new Diarrhea-predominant Irritable Boewl Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.